Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Quipt Home Medical Corp. QIPT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
30/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.70
-53.4%

Quipt Home Medical Corp. (QIPT) is a Medical - Devices company in the Healthcare sector, currently trading at $3.65. It has a SharesGrow Score of 30/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Analyst consensus target is QIPT = $2 (-53.4% upside).

Financials: revenue is $341M, +35.5%/yr average growth. Net income is $11M (loss), growing at -119.6%/yr. Net profit margin is -3.1% (negative). Gross margin is 70.1% (-6.2 pp trend).

Balance sheet: total debt is $119M against $140M equity (Debt-to-Equity (D/E) ratio 0.85, moderate). Current ratio is 1.46 (adequate). Debt-to-assets is 30.1%. Total assets: $394M.

Analyst outlook: 1 / 2 analysts rate QIPT as buy (50%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 10/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 33/100 (Fail), Moat 43/100 (Fail), Future 28/100 (Fail), Income 10/100 (Fail).

$1.70
▼ 53.42% Downside
Average Price Target
The 12-month price target for Quipt Home Medical Corp. is $1.70.

QIPT SharesGrow Score Overview

30/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 10/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 43/100
Gross margin is + market cap
FUTURE 28/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — QIPT

✗
VALUE Fail
10/100
QIPT trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $2, implying -45.2% from the current price $4. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
QIPT: +35.5%/yr revenue is, -119.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
QIPT: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
33/100
Balance sheet QIPT: Debt-to-Equity (D/E) ratio 0.85 (moderate), Current ratio is 1.46 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
43/100
QIPT: Gross margin is 70.1% (-6.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 43/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
28/100
Analyst outlook: 1 / 2 analysts rate QIPT as buy (50%). Analyst consensus target is $2 (-45.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
QIPT: Net profit margin is -3.1%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range1.35-3.65
Volume1.36M
Avg Volume (30D)447K
Market Cap$162.3M
Beta (1Y)0.50
Share Statistics
EPS (TTM)-0.25
Shares Outstanding$43.29M
IPO Date2010-08-10
Employees1,200
CEOGregory John Crawford
Financial Highlights & Ratios
Revenue (TTM)$341.4M
Gross Profit$239.31M
EBITDA$57.4M
Net Income$-10.7M
Operating Income$-5.32M
Total Cash$12.92M
Total Debt$118.79M
Net Debt$105.88M
Total Assets$394.18M
Price / Earnings (P/E)-14.6
Price / Sales (P/S)0.48
Analyst Forecast
1Y Price Target$1.70
Target High$1.70
Target Low$1.70
Upside-53.4%
Rating ConsensusBuy
Analysts Covering2
Buy 50% Hold 50% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCA74880P1045

Price Chart

Track all markets on TradingView
QIPT
Quipt Home Medical Corp. ↗  ·  NASDAQ Capital Marke
Healthcare • Medical - Devices
1.35 52WK RANGE 3.65

People Also View

AORT
AORT
Artivion, Inc.
$37.47
-1.26%
 PRCT
PRCT
PROCEPT BioRobotics Corporation
$25.67
+4.39%
 HSKA
HSKA
Heska Corporation
$119.99
+0.00%
 FNA
FNA
Paragon 28, Inc.
$13.09
+0.00%
 SRDX
SRDX
Surmodics, Inc.
$42.98
+0.35%
 NPCE
NPCE
NeuroPace, Inc.
$15.61
+1.69%
 OFIX
OFIX
Orthofix Medical Inc.
$12.87
+1.18%
 KIDS
KIDS
OrthoPediatrics Corp.
$17.85
-0.06%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message